Clinical Trials Directory

Trials / Unknown

UnknownNCT02630108

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Clinical Study of Transarterial Chemoembolization (TACE) Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
280 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

It is a prospective and multi-center clinical research in China to compare the efficacy, safety and related impact factors between TACE alone and TACE combined with synchronous multi-point MWA/RFA for large and huge liver cancer.

Detailed description

It is an open random prospective phase III clinical trial conducted by Principal Investigator Professor Jian-Hua Wang. Investigators in twenty-five hospitals in China participate in. Patients with unresectable large HCC (\>5cm in diameter) and huge HCC (\>=10cm in diameter) are enrolled. The investigators propose to recruitment 280 patients who are randomly assigned into the combined group (treated with TACE and synchronous ablation) and the control group (treated with TACE alone) according to the proportion of 1:1, which means 140 patients in each group. The criteria of inclusion and exclusion, and the methods of lab tests, imaging modality and treatment procedures are the same.

Conditions

Interventions

TypeNameDescription
PROCEDUREThermal AblationThermal ablation in this trial includes radiofrequency ablation and microwave ablation, one of them can be chosen to be performed.
DRUGEADMEADM is a chemotherapy drug used in transarterial chemoembolization (TACE).Dosage: EADM 30-60 mg per patient,depending on the situation of the patient.
DRUGUltra-fluid lipiodolUltra-fluid lipiodol is a kind of embolization material used in TACE. Standard: 38% ultra-fluid lipiodol .
OTHERGelatin sponge articlesGelatin sponge articles embolization material used in TACE. Standard: 350-560 um in diameter.

Timeline

Start date
2015-12-01
Primary completion
2017-12-01
Completion
2018-04-01
First posted
2015-12-15
Last updated
2016-10-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02630108. Inclusion in this directory is not an endorsement.